Implantable cardioverter-defibrillators

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 13, Issue 4, 1999, Pages 475-483

  Zaidan, James R ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Arrhythmias; Defibrillators; Sudden death; Ventricular defibrillation

Indexed keywords

ANTIARRHYTHMIC AGENT; SOTALOL;

ARTIFICIAL HEART PACEMAKER; CORONARY ARTERY BYPASS GRAFT; DEFIBRILLATION; DEFIBRILLATOR; DISEASE CLASSIFICATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SURVIVAL;

EID: 0032839763     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(99)90226-4     Document Type: Review

References (68)

1. Mirowski M: The automatic implantable cardioverter defibrillator: An overview. J Am Coll Cardiol 6:461-466, 1985
2. O'Callaghan PA, Ruskin JN: Current status of implantable cardioverter-defibrillators. Curr Probl Cardiol 22:641-707, 1997
3. Mower MM: In the beginning: From dogs to humans. PACE 18:506-511, 1995
4. Mirowski M, Mower MM, Staewen WS, et al: Standby automatic defibrillator: An approach to prevention of sudden cardiac death. Arch Intern Med 126:158-161, 1970
5. Mirowski M, Mower MM, Gott VL, et al: Feasability and effectiveness of low-energy catheter defibrillation in man. Circulation 47:79-85, 1973
6. Mirowski M, Reid PR, Mower MM, et al: Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 303:322-324, 1980
7. Mahomed Y: Surgical techniques for implantation of the implantable cardioverer defibrillator, in Zipes DP, Jalife J (eds): Cardiac Electrophysiology: From Cell to Bedside (ed 2). Philadelphia, PA, Saunders, 1995, pp 1403-1412
8. Zipes DP, Roberts D: Results of the international study of the implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead systems - The Pacemaker-Cardioverter-Defibrillator Investigators. Circulation 92:59-65, 1995
9. Hauser RG, Kurschinski DT, McVeigh K, et al: Clinical results with nonthoracotomy ICD systems. Pacing Clin Electrophysiol 16:141-148, 1993
10. Liberthson RR, Nagel EL, Hirschman JC, et al: Prehospital ventricular defibrillation. Prognosis and follow-up course. N Engl J Med 291:317-321, 1974
11. Baum RS, Alvarez H, Cobb LA: Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 50:1231-1235, 1974
12. Cobb LA, Werner JA, Trobaugh GB: Sudden cardiac death. I. A decade's experience with out-of-hospital resuscitation. Mod Concepts Cardiovasc Dis 49:31-36, 1980
13. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 119:1187-1199, 1993
14. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 32:406-412, 1989
15. Singh BN: The coming of age of the class III antiarrhythmic principle: Retrospective and future trends. Am J Cardiol 78:17-27, 1996 (suppl 4A)
16. Zipes DP: Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrests? Circulation 91:2115-2117, 1995
17. Haverkamp W, Eckardt L, Borggrefe M, Breithardt G: Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation and recurrent cardiac arrest. Am J Cardiol 80:67G-73G, 1997
18. Bocker D, Block M, Isbruch F, et al: Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 21:1638-1644, 1993
19. Bocker D, Haverkamp W, Block M, et al: Comparison of d,1-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 94:151-157, 1996
20. Connolly SJ: Heart failure and arrhythmia: Results from the Canadian Implantable Defibrillator Study. American College of Cardiology Meeting, 1998. http://www.medscape.com/medscape/CNO/1998/ ACC/03.30/acco405.conn/acco405.conn.html
21. Connolly SJ, Gent M, Roberts RS, et al, on behalf of the CIDS Co-investigators: Canadian implantable defibrillator study (CIDS): Study design and organization. Am J Cardiol 72:103F-108F, 1993
22. The AVID Investigators: Antiarrhythmics versus implantable defibrillators (AVID): Rationale, design and methods. Am J Cardiol 75:470-475, 1995
23. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators: A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias. N Engl J Med 337:1576-1583, 1997
24. Siebels J, Kuck KH, and the CASH Investigators: Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 127:1139-1144, 1994
25. Siebels J, Cappato R, Ruppel R, et al, and the CASH Investigators: Preliminary results of the cardiac arrest study Hamburg (CASH). Am J Cardiol 72:109F-113F, 1993
26. Moss AJ, Hall WJ, Cannom DS, et al, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933-1940, 1996
27. The CABG Patch Investigators and Coordinators: The Coronary Artery Bypass Graft (CABG) Patch Trial. Prog Cardiovasc Dis 36:97-114, 1993
28. Cannom DS: A review of the implantable cardioverter defibrillator trials. Curr Opin Cardiol 13:3-8, 1998
29. Powell AC, Fuchs T, Finkelstein DM, et al: Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 88:1083-1092, 1993
30. Singer I, Nisam S: There should never be another Antiarrhythmics Versus Implantable Defibrillator (AVID) trial. Am J Cardiol 80:766-768, 1997
31. Saksena S, Madan N, Lewis C: Implantable cardioverterdefibrillators are preferable to drugs: A primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 38:445-454, 1996
32. Bocker D, Block M, Borggrefe M, et al: Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. Eur Heart J 18:26-30, 1997
33. Gregoratos G, Cheitlin MD, Conill A, et al: ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary. J Am Coll Cardiol 31:1175-1206, 1998
34. Olsen WH: Tachyarrhythmias sensing and detection, in Singer I (ed): Implantable cardioverter-defibrillators: Prospective comparison of different lead system-device combinations. Circulation 93:91-98, 1996
35. Guidant Corportion/Cardiac Pacemakers (CPI): Ventak® Mini™ Physician's System Manual. St Paul, Minnesota, CPI, chapt 3, Tachyarrhythmia detection
36. Neuzner J, Pitschner HF, Huth C, et al: Effect of biphasic waveform pulse on endocardial defibrillation efficacy in humans. Pacing Clin Electrophysiol 17:207-212, 1994
37. Block M, Hammel D, Bocker D, et al: A prospectice randomised cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 5:581-590, 1994
38. Rosenqvist M: Pacing techniques to terminate ventricular tachycardia. Pacing Clin Electrophysiol 18:592-598, 1995
39. The PCD Investigator Group: Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study. J Am Coll Cardiol 23:1521-1530, 1994
40. Porterfield JG, Porterfield LM, Smith BA, Ventak PRx Phase I Investigators: Conversion rates of induced versus spontaneous ventricular tachycardia by a third-generation cardioverter defibrillator. Pacing Clin Electrophysiol 16:170-178, 1993
41. Echt DS, Armstrong K, Schmidt P, et al: Clinical experience, complications and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 71:289-296, 1985
42. Kelly PA, Cannom DS, Garan H, et al: The automatic implantable cardioverter-defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 11:1278-1286, 1988
43. Winkle RA, Mead RH, Ruder MA, et al: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 13:1353-1361, 1989
44. Epstein AE, Kay GN, Plumb VJ, et al: Combined automatic implantable cardioverter-defibrillator and pacemaker systems: Implantation techniques and follow-up. J Am Coll Cardiol 13:121-131, 1989
45. Calkins H, Brinker J, Veltri EP, et al: Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol 16:666-673, 1990
46. Brooks R, Garan H, McGovern BA, et al: Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J 129:45-53, 1995
47. Leitch JW, Gillis AM, Wyse G, et al: Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy. J Am Coll Cardiol 18:145-151, 1991
48. Bardy GH, Troutman C, Poole JE, et al: Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device. Circulation 85:1689-1698, 1992
49. Manz M, Jung W, Luderitz B: Interactions between drugs and devices: Experimental and clinical studies. Am Heart J 127:978-984, 1994
50. Rabinovich R, Muratore C, Iglesias R, et al: Results of delivered therapy of VT or VF in patients with third-generation implantable cardioverter defibrillators. PACE 18:133-136, 1995
51. Slepian M, Levine JH, Watkins L Jr, et al: Automatic implantable cardioverter defibrillator/pacemaker interaction: Loss of pacemaker capture following AICD discharge. PACE 10:1194-1197, 1987
52. Brode SE, Schwartzman D, Callans DJ: ICD-antiarrhythmic drug and ICD-pacemaker interactions. J Cardiovasc Electrophysiol 8:830-842, 1997
53. Levine PA: Effect of cardioversion and defibrillation on implanted cardiac pacemakers, in Barold SS (ed): Modern Cardiac Pacing. Mount Kisco, NY, Futura, 1985, pp 875-886
54. Das G, Eaton J: Pacemaker malfunction following transthoracic countershock. PACE 4:487-490, 1981
55. Cohen AI, Wish MH, Fletcher RD, et al: The use and interaction of permanent pacemakers and the automatic implantable cardioverterdefibrillator. PACE 11:704-711, 1988
56. Barold SS, Ong LS, Scovil IJ, et al: Reprogramming of implanted pacemaker following external defibrillation. PACE 1:514-520, 1978
57. Ching E, Carlblom D, Wilkoff BL, et al: Risk of pacemaker damage induced by implantable defibrillator shocks. PACE 14:629, 1991
58. Pinski SL, Fahy GJ: The proarrhythmic potential of implantable cardioverter-defibrillators. Circulation 92:1651-1664, 1995
59. Clemo HF, Ellenbogen KA, Belz MK, et al: Safety of pacemaker implantation in patients with transvenous (nonthoracotomy) implantable cardioverter defibrillators. PACE 17:2285-2290, 1994
60. Chapman PD, Troup P: The automatic implantable cardioverterdefibrillator. Evaluating suspected inappropriate shocks. J Am Coll Cardiol 7:1075-1078, 1986
61. Blanck Z, Niazi I, Axtell K, et al: Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems. Am J Cardiol 74:1249-1253, 1994
62. Kim SG, Furman S, Waspe LE, et al: Unipolar pacer artifacts induced failure of an automatic implantable cardioverter/defibrillator to detect ventricular fibrillation. Am J Cardiol 57:880-881, 1986
63. Gottlieb CD, Miller JM, Rosenthal ME, et al: Automatic implantable defibrillator discharge resulting from routine pacemaker programming. PACE 11:336-338, 1988
64. Kim SG, Furman S, Matos JA, et al: Automatic implantable cardioverter/defibrillotor. Inadvertent discharges during permanent pacemaker magnet tests. PACE 10:579-582, 1987
65. Guidant Corportion/Cardiac Pacemakers (CPI): Ventak® Mini™ Physician's System Manual. St Paul, Minnesota, CPI, chapt 1, Description and use
66. Guidant Corportion/Cardiac Pacemakers (CPI): Ventak® Mini™ Physician's System Manual. St Paul, Minnesota, CPI, chapt 9, using the magnet
67. Medtronic, Inc: Micro Jewel II. Product Information Manual. Minneapolis, Minnesota, Medtronic Inc, chapt 1
68. Sulzer Intermedics, Inc: Res-Q Micron Physician's Manual, Angleton, Texas, Sulzer Intermedics Inc, chapter 5